Apgar评分联合脐动脉血pH与极早产儿不良结局
该队列研究基于EPICE项目,纳入2011年4月至2012年9月11个欧洲国家<32周极早产活产儿中同时有Apgar评分和脐动脉血pH数据的4174例(占7900例的52.8%)。将5分钟Apgar评分(<7 vs ≥7)与脐动脉血pH(<7.20 vs ≥7.20)交叉分为四组,采用改良Poisson回归估计死亡和/或严重新生儿疾病复合结局及死亡、IVH、BPD的校正相对风险。Apgar评分<7组复合结局频率在pH正常者为48.4%、pH低者为55.1%(参照组均为19.5%),校正RR均为1.4;死亡风险仅在Apgar评分<7且pH低者中稳健升高(ARR 2.4),Apgar评分≥7且pH低者死亡风险未显著升高(ARR 1.2,95%CI 0.8-1.8)但IVH风险升高(ARR 2.0)。作者认为联合脐动脉血pH与5分钟Apgar评分可提高对部分不良结局(尤其是出生后不久的死亡和IVH)的风险估计准确性。
要点
- 极早产儿中Apgar评分<7且脐动脉血pH<7.20者死亡风险最高:ARR 2.4(95%CI 1.7-3.3)。
- Apgar评分<7者复合结局风险升高,pH正常者ARR 1.4(95%CI 1.3-1.6),pH低者ARR 1.4(95%CI 1.2-1.7)。
- Apgar评分≥7但脐动脉血pH<7.20者死亡风险未显著升高(ARR 1.2,95%CI 0.8-1.8),但IVH风险升高(ARR 2.0,95%CI 1.3-3.0)。
- BPD风险仅与Apgar评分<7且pH正常相关:ARR 1.4(95%CI 1.2-1.7)。
- 作者认为联合脐动脉血pH与5分钟Apgar评分可提高对死亡和IVH等出生后不久发生的不良结局的风险估计准确性。
适用人群与场景
- 胎龄<32周的极早产活产儿,来自2011年4月至2012年9月11个欧洲国家的EPICE队列。
- 纳入标准:有Apgar评分和脐动脉血pH数据的活产极早产儿,共4174例(占7900例的52.8%)。
诊断标准与关键阈值
- Apgar评分分类:5分钟Apgar评分<7为低,≥7为正常。
- 脐动脉血pH分类:<7.20为低,≥7.20为正常。
- 四组定义:Apgar评分<7且pH低;Apgar评分<7且pH正常;Apgar评分≥7且pH低;Apgar评分≥7且pH正常。
研究设计与关键结果
- 研究类型:队列研究(EPICE项目),纳入11个欧洲国家2011年4月至2012年9月胎龄<32周的活产极早产儿7900例,其中4174例(52.8%)有Apgar评分和脐动脉血pH数据;男性2249例(53.9%),中位胎龄29.9周(IQR 27.9-31.0),中位出生体重1240 g(IQR 960-1520)。
- 分组:Apgar评分≥7且pH低367例(8.8%),Apgar评分<7且pH正常558例(13.4%),Apgar评分<7且pH低196例(4.7%)。
- 复合结局(死亡和/或任何不良疾病:IVH>2级、囊性PVL、中重度BPD、ROP≥2期、NEC):Apgar评分<7且pH正常组270例(48.4%),Apgar评分<7且pH低组108例(55.1%),参照组(Apgar评分≥7且pH正常)596例(19.5%);校正RR分别为1.4(95%CI 1.3-1.6)和1.4(95%CI 1.2-1.7)。
- 死亡风险:Apgar评分<7且pH低者ARR 2.4(95%CI 1.7-3.3);Apgar评分≥7且pH低者ARR 1.2(95%CI 0.8-1.8),未达统计学显著。
- IVH风险:三个亚组均升高,包括Apgar评分≥7且pH低者ARR 2.0(95%CI 1.3-3.0)。
- BPD风险:仅与Apgar评分<7且pH正常相关,ARR 1.4(95%CI 1.2-1.7)。
证据类型、等级与局限
- 证据类型:队列研究(EPICE项目)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,联合脐动脉血pH与5分钟Apgar评分可提高对部分不良结局(尤其是出生后不久的死亡和IVH)的风险估计准确性。
- 作者认为,应分别探讨早期风险标志物与新生儿死亡和关键新生儿疾病的关联。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: The Apgar score, the first clinical assessment to direct measures to stabilize newborn infants, is also used for risk assessment. Its accuracy in estimating outcomes remains poor among very preterm (VPT) infants.
OBJECTIVE: To assess the utility of the combined 5-minute Apgar score and umbilical artery pH (UA-pH) for estimating risks of mortality and severe neonatal morbidity among VPT infants.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study (Effective Perinatal Intensive Care in Europe [EPICE]) analyzed infants born at less than 32 weeks' gestation between April 2011 and September 2012 across 11 European countries. All liveborn VPT infants with Apgar scores and UA-pH data were included. Data were analyzed between February and December 2025.
EXPOSURES: Apgar score at 5 minutes and UA-pH. The Apgar score was classified as lower than 7 and 7 or higher, and the UA-pH values were categorized as low (<7.20) and normal (≥7.20). Four groups that combined these 2 measures were defined: Apgar score lower than 7 and low UA-pH; Apgar score lower than 7 and normal UA-pH; Apgar score 7 or higher and low UA-pH; and Apgar score 7 or higher and normal UA-pH.
MAIN OUTCOMES AND MEASURES: Combined outcome of mortality and/or any adverse morbidity (intraventricular hemorrhage [IVH] >grade 2, cystic periventricular leukomalacia, moderate or severe bronchopulmonary dysplasia [BPD], retinopathy of prematurity ≥stage 2, and necrotizing enterocolitis). Modified Poisson regression was used to estimate relative risks (RRs) between the exposure and the combined mortality and morbidity outcome and 3 individual components: mortality, IVH, and BPD. Models were adjusted for perinatal variables associated with Apgar score and UA-pH and adverse neonatal outcomes.
RESULTS: Of 7900 liveborn infants in the EPICE cohort, 4174 (52.8%) had information on Apgar score and UA-pH. These infants included 2249 males (53.9%) and had a median [IQR] gestational age of 29.9 [27.9-31.0] weeks and median [IQR] birth weight of 1240 [960-1520] g. A total of 367 infants (8.8%) had an Apgar score 7 or higher but a low UA-pH, 558 (13.4%) had an Apgar score lower than 7 but a normal UA-pH, and 196 (4.7%) had an Apgar score lower than 7 and a low UA-pH. Infants with an Apgar score lower than 7 had a higher frequency of the combined outcome among those with a normal UA-pH (270 [48.4%] vs 596 [19.5%]) and a low UA-pH (108 [55.1%] vs 596 [19.5%]), with similar adjusted RRs (ARRs; low: 1.4 [95% CI, 1.2-1.7]; normal: 1.4 [95% CI, 1.3-1.6]). For mortality risk, associations were robust for an Apgar score lower than 7 and a low UA-pH (ARR, 2.4; 95% CI, 1.7-3.3) and absent with an Apgar score of 7 or higher and a low UA-pH (ARR, 1.2; 95% CI, 0.8-1.8). IVH risk was increased in all 3 subcategories, including an Apgar score of 7 or higher with a low UA-pH (ARR, 2.0; 95% CI, 1.3-3.0). BPD risk was associated only with an Apgar score lower than 7 and a normal UA-pH (ARR, 1.4; 95% CI, 1.2-1.7).
CONCLUSIONS AND RELEVANCE: In this cohort study of VPT infants, combining information on UA-pH with the 5-minute Apgar score was associated with improved accuracy in estimating the risk of some adverse outcomes-notably mortality and IVH, which occurred soon after birth. These results highlight the importance of exploring the associations of early markers of risk with neonatal mortality and key neonatal morbidities separately.
参考来源
- Ehrhardt H, Behboodi S, Maier RF, et al. Apgar Score Plus Umbilical Artery pH and Adverse Neonatal Outcomes in Very Preterm Infants. JAMA Netw Open. 2026. PMID: 41649815. doi:10.1001/jamanetworkopen.2025.57913
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。